I think this would make for an effective treatment via monoclonal antibodies wouldn't it? i.e. have a bioreactor manufacture the antibodies and administer them

I think this would make for an effective treatment via monoclonal antibodies wouldn't it? i.e. have a bioreactor manufacture the antibodies and administer them to people who contract the disease.